Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients
Author(s) -
Barbara SeitzPolski,
Christine Payré,
Damien Ambrosetti,
Laetitia Albano,
E. CassutoViguier,
M. Berguignat,
Ahmed Jeribi,
Marie-Christine Thouret,
Ghislaine Bernard,
Sylvia Benzaken,
Gérard Lambeau,
Vincent Esnault
Publication year - 2014
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfu252
Subject(s) - medicine , autoantibody , membranous nephropathy , transplantation , receptor , phospholipase a2 , kidney transplantation , immunology , gastroenterology , glomerulonephritis , pathology , kidney , antibody , enzyme , biochemistry , biology
The predictive value of anti-M-type phospholipase A2 receptor (PLA2R1) autoantibodies for membranous nephropathy (MN) recurrence after renal transplantation remains controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom